We appreciate Dr. Selinger’s insightful observations regarding the overtreatment of patients with subclinical hypothyroidism. His emphasis on the potential harms associated with overtreatment is particularly valuable. The issue of overprescribing levothyroxine, especially in patients under 65 with normal thyrotropin levels or mild subclinical hypothyroidism, by practitioners outside of primary care or endocrinology indeed warrants further investigation. We agree that this topic deserves a dedicated and comprehensive review in the future.
- Copyright © 2025 The Cleveland Clinic Foundation. All Rights Reserved.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.